CN103989206A - 一种含gaba的减压营养保健品及其制备方法 - Google Patents
一种含gaba的减压营养保健品及其制备方法 Download PDFInfo
- Publication number
- CN103989206A CN103989206A CN201410226715.9A CN201410226715A CN103989206A CN 103989206 A CN103989206 A CN 103989206A CN 201410226715 A CN201410226715 A CN 201410226715A CN 103989206 A CN103989206 A CN 103989206A
- Authority
- CN
- China
- Prior art keywords
- parts
- walnut
- decompression
- gaba
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title claims abstract description 35
- 229960003692 gamma aminobutyric acid Drugs 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 title abstract 6
- 230000000991 decompressive effect Effects 0.000 title abstract 5
- 235000015872 dietary supplement Nutrition 0.000 title abstract 5
- 235000020234 walnut Nutrition 0.000 claims abstract description 81
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 33
- 241000222336 Ganoderma Species 0.000 claims abstract description 31
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 28
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 28
- 235000012907 honey Nutrition 0.000 claims abstract description 27
- 240000007087 Apium graveolens Species 0.000 claims abstract description 22
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 15
- 210000000582 semen Anatomy 0.000 claims abstract description 14
- 244000269722 Thea sinensis Species 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 10
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 10
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 10
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 10
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract 4
- 241000758789 Juglans Species 0.000 claims description 68
- 235000009496 Juglans regia Nutrition 0.000 claims description 68
- 239000000843 powder Substances 0.000 claims description 41
- 230000006837 decompression Effects 0.000 claims description 38
- 244000197580 Poria cocos Species 0.000 claims description 32
- 239000007788 liquid Substances 0.000 claims description 30
- 239000012452 mother liquor Substances 0.000 claims description 28
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 21
- 235000010591 Appio Nutrition 0.000 claims description 21
- 235000015097 nutrients Nutrition 0.000 claims description 21
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 20
- 239000012535 impurity Substances 0.000 claims description 20
- 239000013078 crystal Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 235000011194 food seasoning agent Nutrition 0.000 claims description 12
- 238000000227 grinding Methods 0.000 claims description 12
- 238000002386 leaching Methods 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 11
- 240000005385 Jasminum sambac Species 0.000 claims description 11
- 238000013467 fragmentation Methods 0.000 claims description 9
- 238000006062 fragmentation reaction Methods 0.000 claims description 9
- 235000007215 black sesame Nutrition 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 8
- 238000012859 sterile filling Methods 0.000 claims description 8
- 238000005507 spraying Methods 0.000 claims description 4
- 239000000047 product Substances 0.000 abstract description 21
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 15
- 241000758791 Juglandaceae Species 0.000 abstract description 13
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 230000002860 competitive effect Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 235000002764 Apium graveolens Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 239000001387 apium graveolens Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 13
- 241000723353 Chrysanthemum Species 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 241001570521 Lonicera periclymenum Species 0.000 description 6
- 230000001093 anti-cancer Effects 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 5
- 230000001077 hypotensive effect Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 4
- 208000001953 Hypotension Diseases 0.000 description 4
- 241000245240 Lonicera Species 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 235000004879 dioscorea Nutrition 0.000 description 4
- 208000021822 hypotensive Diseases 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 1
- NTDLXWMIWOECHG-UHFFFAOYSA-N 7-labden-3beta,15-diol Natural products O1CC(O)(CO)C(O)C1OC1C(O)C(O)C(CO)OC1OC(C=1)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 NTDLXWMIWOECHG-UHFFFAOYSA-N 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000002456 anti-arthritic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- NTDLXWMIWOECHG-YRCFQSNFSA-N apiin Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O[C@H]1[C@@H]([C@@](O)(CO)CO1)O)O)CO)C(C=1)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 NTDLXWMIWOECHG-YRCFQSNFSA-N 0.000 description 1
- NTDLXWMIWOECHG-WJAPLXOZSA-N apiin Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1cc(O)c2C(=O)C=C(c3ccc(O)cc3)Oc2c1)[C@H]1[C@@H](O)[C@@](O)(CO)CO1 NTDLXWMIWOECHG-WJAPLXOZSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- -1 triterpene compound Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/90—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in food processing or handling, e.g. food conservation
- Y02A40/924—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in food processing or handling, e.g. food conservation using renewable energies
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种含GABA的减压营养保健品，由以下重量份的组分制成：核桃1～15份、灵芝0.5～15份、茶多酚0.001～0.01份、GABA0.01～0.1份、黑芝麻1～15份、茯苓0.5～15份、金银花0.5～10份、菊花0.5～10份、苦丁0.5～10份、山药0.5～8份、芹菜0.5～8份、蜂蜜10～50份、其余为水，以及公开了一种含GABA的减压营养保健品制备方法，该制备方法简单，生产成本低，制得的产品不但可降低血脂、血压，而且还可缓解处于忙碌、高竞争人群的压力。
Description
技术领域
本发明涉及一种含GABA的减压营养保健品及其制备方法。
背景技术
GABA是中枢神经系统中很重要的抑制性神经递质，它是一种天然存在的非蛋白组成氨基酸，具有极其重要的生理功能，它能促进脑的活化性，健脑益智，抗癫痫，促进睡眠，美容润肤，延缓脑衰老机能，能补充人体抑制性神经递质，具有良好的降血压功效，促进肾机能改善和保护作用，抑制脂肪肝及肥胖症，活化肝功能。每日补充微量的GABA有利于心脑血压的缓解，又能促进人体内氨基酸代谢的平衡，调节免疫功能。
灵芝，富含灵芝多糖，具有免疫调节、降血糖、降血脂、抗氧化、抗衰老及抗肿瘤作用；还含有三萜类化合物，可以净化血液，保护肝功能；灵芝可显著提高机体免疫力和防癌、抗癌能力，具有镇静、抗惊厥、强心、抗心律失常、降压、镇咳平踹作用。
茶多酚，是茶叶中多酚类物质的总称，可以抗癌、防治心血管疾病以及提高综合免疫力等作用。另外，茶多酚还具有降血脂，预防肝脏及冠状动脉粥样硬化，降血压，降血糖，防治脑中风，抗血栓的作用。
茯苓，多孔菌科真菌茯苓的菌核，具有健脾化痰、宁心安神等传统功效。茯苓中的茯苓酸具有增强免疫力、抗肿瘤以及镇静、降血糖等作用；茯苓中的茯苓聚糖含量很高，可以预防消化道溃疡，保护肝脏，调节免疫力等功能。
黑芝麻，含有大量脂肪、蛋白质、多种不饱和脂肪酸、维生素E和珍贵的芝麻素及黑色素，营养价值丰富。因此，具有补钙、降血压、养颜润肤等功效。
蜂蜜，能改善血液的成份，促进心脑和血管功能；对肝脏有保护作用，能促使肝细胞再生，对脂肪肝的形成有一定的抑制作用；能够安神，润肠通便，对中老年失眠及便秘人群有一定的帮助；具有良好的抗氧化作用，清除体内氧自由基，达到抗癌、防衰老的作用。食用蜂蜜能迅速补充体力，消除疲劳，增强对疾病的抵抗力。
金银花，性味甘、寒，具有清热解毒、抗炎补虚、减肥消脂、抑菌抗病毒等功效，临床应用广泛。对其组成成分进行研究发现，其富含绿原酸，现代科学对绿原酸的活性研究已深入到食品、保健品等领域，作为一种重要的生物活性物质，具有抗菌、抗病毒、降血压、清血脂、抗氧化等多种生理功能。
菊花，味甘苦，微寒，散风，清热解毒。对其组成进行研究发现，菊花含有芹菜素、木犀草素、槲皮素等黄酮类物质，菊醇、龙脑、樟脑等挥发油类物质，以及17种氨基酸和铜、铁、锌、锰、硒等微量元素。
苦丁，性寒味苦，含有人体必需的多种氨基酸、维生素以及锌、锰、铁等微量元素，具有散风热、清头目、除烦渴、降血脂、改善心肌供血、抗动脉粥样硬化等作用。
山药，富含多种维生素、氨基酸和矿物质，具有降血糖、降血脂、以及预防动脉硬化，特别是具有降血糖作用，同时具有抗关节炎、抑制突变作用。
芹菜，含有芹菜苷、佛手苷内酯和挥发油，具有降血压、降血脂、防治动脉粥样硬化作用；同时具有镇静安神、利尿消肿、防癌、抗癌等功效。
现在高血压、高血脂已经是一种常见的高发疾病，随着人们生活水平的提高，人们的饮食越来越丰富，人们摄取的营养也越来越丰富，但是相对的人们的运动量却越来越小，从而造成了高血压、高血脂的高发。高血脂对人体的危害非常之大，并且往往伴随有高血压，不及时控制及治疗会引起脑卒中、冠心病、脑梗塞、肾衰竭等恶性疾病，严重危害人们的身体健康。
而随着社会的高速发展，压力也已经成为威胁人们健康的问题之一。当前，竞争压力越来越激烈，人们承受着工作、人际和情感等多重压力，精神长期处于高度紧张状态，长此下去，会让机体免疫力变差，造成对人们的身心健康极大的威胁。
发明内容
本发明要解决的技术问题是提供一种具有良好减压效果的含GABA的减压营养保健品，不但可降低血脂、血压，而且还可缓解处于忙碌、高竞争人群的压力，该含GABA的减压营养保健品制备方法简单，生产成本低。
为解决上述技术问题，本发明采用的技术方案是：一种含GABA的减压营养保健品，包括减压营养粉、减压花茶和减压果蔬汁，所述减压营养粉由以下重量份的组分制成：核桃1～10份、灵芝0.5～10份、茶多酚0.001～0.01份、GABA0.01～0.1份、黑芝麻1～10份、茯苓0.5～10份、蜂蜜10～50份、其余为水；所述减压花茶由以下重量份的组分制成：核桃1～10份、灵芝0.5～10份、茶多酚0.001～0.01份、GABA0.01～0.1份、茯苓0.5～10份、金银花0.5～5份、菊花0.5～5份、苦丁0.5～5份、蜂蜜10～50份、其余为水；所述减压果蔬汁由以下重量份的组分制成：核桃1～10份、灵芝0.5～10份、茶多酚0.001～0.01份、GABA0.01～0.1份、茯苓0.5～10份、山药0.5～5份、芹菜0.5～5份、蜂蜜10～50份、其余为水。
一种含GABA的减压营养保健品制备方法，包括以下步骤：
步骤1、将核桃、灵芝、黑芝麻、茯苓、金银花、菊花、苦丁、山药、芹菜分别进行除杂、清洗处理；
步骤2、将经步骤1处理后的核桃放入太阳能核桃破壳机进行破碎，破碎后分离核桃壳和核桃仁，然后将分离出来的核桃仁进行超微粉碎，形成核桃粉；将经步骤1处理后的黑芝麻进行超微粉碎，形成黑芝麻粉；
步骤3、将经步骤1处理后的灵芝、茯苓放入浸提装置，在60～70℃下浸提3h，然后经过过滤、去除杂质，制得清澈透明液，即母液Ⅰ；将经步骤1处理后的金银花、菊花、苦丁放入浸提装置，在60～70℃下浸提3h，然后经过过滤、去除杂质，制得清澈透明液，即母液Ⅱ；将经步骤1处理后的山药、芹菜分别进行打浆和过滤，制得山药汁和芹菜汁；
步骤4、将核桃粉、母液Ⅰ混合，再添加黑芝麻粉、茶多酚和GABA，混合均匀后，加入适量蜂蜜进行调味，然后在压力为15～20Mpa的条件下进行均质，均质后在温度为138℃的条件下进行超高温灭菌4s，最后，通过喷雾干燥制得减压营养粉；将核桃粉、母液Ⅰ和母液Ⅱ混合，再添加茶多酚和GABA，混合均匀后，加入适量蜂蜜进行调味，然后在压力为15～20Mpa的条件下进行均质，均质后在温度为138℃的条件下进行超高温灭菌4s，最后，通过无菌灌装制得减压花茶或者通过液体浓缩制得浓缩生产口服液；将核桃粉、母液Ⅰ、山药汁和芹菜汁混合，再添加茶多酚和GABA，混合均匀后，加入适量蜂蜜进行调味，然后在压力为15～20Mpa的条件下进行均质，均质后在温度为138℃的条件下进行超高温灭菌4s，最后，通过无菌灌装制得减压果蔬汁或者通过液体浓缩制得浓缩生产口服液。
本发明采用的技术方案，其有益效果在于：(1)本发明产品包括营养粉、口服液和液体饮料，产品多样化，拓宽了产品市场；(2)本发明产品包括减压茶和减压果蔬汁，口味多样化，使消费者可以现在适合自己的口味；(3)本发明产品营养丰富，具有降血脂、降血压的效果，同时还对大脑神经有一定的辅助作用，可起到降低脑部压力的作用，适合处于压力状态下的人群，需要营养补充的儿童、青少年和有高血脂、高血压的老龄人群，适用人群广泛；(4)本发明产品制备方法采用超微粉碎技术，利用机械或流动动力的方法克服固体内部凝聚力使其破碎，可将物料颗粒粉碎至10-25μm，得到的超微粉具有良好的溶解性、分散性、吸附性和化学方应活性，可以使得产品具有更好的溶解性和口感。
附图说明
下面结合附图对本发明做进一步说明：
图1是本发明实施例1和实施例2的制备工艺示意图；
图2是本发明实施例3和实施例4的制备工艺示意图；
图3是本发明实施例5和实施例6的制备工艺示意图。
具体实施方式
本发明是一种含GABA的减压营养保健品，包括减压营养粉、减压花茶和减压果蔬汁。
实施例1
本实施例中，一种减压营养粉由以下重量份的组分制成：核桃15份、灵芝15份、茶多酚0.01份、GABA0.1份、黑芝麻15份、茯苓15份、蜂蜜20份、其余为水。
如图1所示，产品制备工艺包括以下步骤：
步骤1、将核桃、灵芝、黑芝麻、茯苓分别进行除杂、清洗处理；
步骤2、将经步骤1处理后的15份核桃放入太阳能核桃破壳机进行破碎，破碎后分离核桃壳和核桃仁，然后将分离出来的核桃仁进行超微粉碎，形成核桃粉；将经步骤1处理后的15份黑芝麻进行超微粉碎，形成黑芝麻粉；
步骤3、将经步骤1处理后的15份灵芝、15份茯苓放入浸提装置，在60℃下浸提3h，然后经过过滤、去除杂质，制得清澈透明液，即母液Ⅰ；
步骤4、将核桃粉、母液Ⅰ混合，再添加黑芝麻粉、0.01份茶多酚和0.1份GABA，混合均匀后，加入20份蜂蜜进行调味，然后在压力为15Mpa的条件下进行均质，均质后在温度为138℃的条件下进行超高温灭菌4s，最后，通过喷雾干燥制得减压营养粉。
实施例2
本实施例中，一种减压营养粉由以下重量份的组分制成：核桃10份、灵芝10份、茶多酚0.005份、GABA0.05份、黑芝麻10份、茯苓10份、蜂蜜30份、其余为水。
如图1所示，产品制备工艺包括以下步骤：
步骤1、将核桃、灵芝、黑芝麻、茯苓分别进行除杂、清洗处理；
步骤2、将经步骤1处理后的10份核桃放入太阳能核桃破壳机进行破碎，破碎后分离核桃壳和核桃仁，然后将分离出来的核桃仁进行超微粉碎，形成核桃粉；将经步骤1处理后的10份黑芝麻进行超微粉碎，形成黑芝麻粉；
步骤3、将经步骤1处理后的10份灵芝、10份茯苓放入浸提装置，在70℃下浸提3h，然后经过过滤、去除杂质，制得清澈透明液，即母液Ⅰ；
步骤4、将核桃粉、母液Ⅰ混合，再添加黑芝麻粉、0.005份茶多酚和0.05份GABA，混合均匀后，加入30份蜂蜜进行调味，然后在压力为20Mpa的条件下进行均质，均质后在温度为138℃的条件下进行超高温灭菌4s，最后，通过喷雾干燥制得减压营养粉。
实施例3
本实施例中，一种减压花茶由以下重量份的组分制成：核桃10份、灵芝5份、茶多酚0.005份、GABA0.05份、茯苓5份、金银花5份、菊花5份、苦丁5份、蜂蜜30份、其余为水。
如图2所示，产品制备工艺包括以下步骤：
步骤1、将核桃、灵芝、茯苓、金银花、菊花、苦丁分别进行除杂、清洗处理；
步骤2、将经步骤1处理后的10份核桃放入太阳能核桃破壳机进行破碎，破碎后分离核桃壳和核桃仁，然后将分离出来的核桃仁进行超微粉碎，形成核桃粉；
步骤3、将经步骤1处理后的5份灵芝、5份茯苓放入浸提装置，在60℃下浸提3h，然后经过过滤、去除杂质，制得清澈透明液，即母液Ⅰ；将经步骤1处理后的5份金银花、5份菊花、5份苦丁放入浸提装置，在70℃下浸提3h，然后经过过滤、去除杂质，制得清澈透明液，即母液Ⅱ；
步骤4、将核桃粉、母液Ⅰ和母液Ⅱ混合，再添加0.005份茶多酚和0.05份GABA，混合均匀后，加入30份蜂蜜进行调味，然后在压力为15Mpa的条件下进行均质，均质后在温度为138℃的条件下进行超高温灭菌4s，最后，通过无菌灌装制得减压花茶或者通过液体浓缩制得浓缩生产口服液。
实施例4
本实施例中，一种减压花茶由以下重量份的组分制成：核桃10份、灵芝5份、茶多酚0.005份、GABA0.05份、茯苓6份、金银花10份、菊花10份、苦丁10份、蜂蜜20份、其余为水。
如图2所示，产品制备工艺包括以下步骤：
步骤1、将核桃、灵芝、茯苓、金银花、菊花、苦丁分别进行除杂、清洗处理；
步骤2、将经步骤1处理后的10份核桃放入太阳能核桃破壳机进行破碎，破碎后分离核桃壳和核桃仁，然后将分离出来的核桃仁进行超微粉碎，形成核桃粉；
步骤3、将经步骤1处理后的5份灵芝、6份茯苓放入浸提装置，在70℃下浸提3h，然后经过过滤、去除杂质，制得清澈透明液，即母液Ⅰ；将经步骤1处理后的10份金银花、10份菊花、10份苦丁放入浸提装置，在70℃下浸提3h，然后经过过滤、去除杂质，制得清澈透明液，即母液Ⅱ；
步骤4、将核桃粉、母液Ⅰ和母液Ⅱ混合，再添加0.005份茶多酚和0.05份GABA，混合均匀后，加入20份蜂蜜进行调味，然后在压力为20Mpa的条件下进行均质，均质后在温度为138℃的条件下进行超高温灭菌4s，最后，通过无菌灌装制得减压花茶或者通过液体浓缩制得浓缩生产口服液。
实施例5
本实施例中，一种减压果蔬汁由以下重量份的组分制成：核桃8份、灵芝5份、茶多酚0.01份、GABA0.05份、茯苓8份、山药8份、芹菜5份、蜂蜜30份、其余为水。
如图3所示，产品制备工艺包括以下步骤：
步骤1、将核桃、灵芝、茯苓、山药、芹菜分别进行除杂、清洗处理；
步骤2、将经步骤1处理后的8份核桃放入太阳能核桃破壳机进行破碎，破碎后分离核桃壳和核桃仁，然后将分离出来的核桃仁进行超微粉碎，形成核桃粉；
步骤3、将经步骤1处理后的5份灵芝、8份茯苓放入浸提装置，在60℃下浸提3h，然后经过过滤、去除杂质，制得清澈透明液，即母液Ⅰ；将经步骤1处理后的8份山药、5份芹菜分别进行打浆和过滤，制得山药汁和芹菜汁；
步骤4、将核桃粉、母液Ⅰ、山药汁和芹菜汁混合，再添加0.01份茶多酚和0.05份GABA，混合均匀后，加入30份蜂蜜进行调味，然后在压力为15Mpa的条件下进行均质，均质后在温度为138℃的条件下进行超高温灭菌4s，最后，通过无菌灌装制得减压果蔬汁或者通过液体浓缩制得浓缩生产口服液。
实施例6
本实施例中，一种减压果蔬汁由以下重量份的组分制成：核桃8份、灵芝5、茶多酚0.01份、GABA0.05份、茯苓5份、山药5份、芹菜8份、蜂蜜30份和、其余为水。
如图3所示，产品制备工艺包括以下步骤：
步骤1、将核桃、灵芝、茯苓、山药、芹菜分别进行除杂、清洗处理；
步骤2、将经步骤1处理后的8份核桃放入太阳能核桃破壳机进行破碎，破碎后分离核桃壳和核桃仁，然后将分离出来的核桃仁进行超微粉碎，形成核桃粉；
步骤3、将经步骤1处理后的5份灵芝、5份茯苓放入浸提装置，在70℃下浸提3h，然后经过过滤、去除杂质，制得清澈透明液，即母液Ⅰ；将经步骤1处理后的5份山药、8份芹菜分别进行打浆和过滤，制得山药汁和芹菜汁；
步骤4、将核桃粉、母液Ⅰ、山药汁和芹菜汁混合，再添加0.01份茶多酚和0.05份GABA，混合均匀后，加入30份蜂蜜进行调味，然后在压力为20Mpa的条件下进行均质，均质后在温度为138℃的条件下进行超高温灭菌4s，最后，通过无菌灌装制得减压果蔬汁或者通过液体浓缩制得浓缩生产口服液。
除上述优选实施例外，本发明还有其他的实施方式，本领域技术人员可以根据本发明作出各种改变和变形，只要不脱离本发明的精神，均应属于本发明所附权利要求所定义的范围。
Claims (2)
1.一种含GABA的减压营养保健品，其特征在于：包括减压营养粉、减压花茶和减压果蔬汁，所述减压营养粉由以下重量份的组分制成：核桃1～15份、灵芝0.5～15份、茶多酚0.001～0.01份、GABA0.01～0.1份、黑芝麻1～15份、茯苓0.5～15份、蜂蜜10～50份、其余为水；所述减压花茶由以下重量份的组分制成：核桃1～15份、灵芝0.5～15份、茶多酚0.001～0.01份、GABA0.01～0.1份、茯苓0.5～15份、金银花0.5～10份、菊花0.5～10份、苦丁0.5～10份、蜂蜜10～50份、其余为水；所述减压果蔬汁由以下重量份的组分制成：核桃1～15份、灵芝0.5～15份、茶多酚0.001～0.01份、GABA0.01～0.1份、茯苓0.5～15份、山药0.5～8份、芹菜0.5～8份、蜂蜜10～50份、其余为水。
2.一种根据权利要求1所述的含GABA的减压营养保健品制备方法，其特征在于：包括以下步骤：
步骤1、将核桃、灵芝、黑芝麻、茯苓、金银花、菊花、苦丁、山药、芹菜分别进行除杂、清洗处理；
步骤2、将经步骤1处理后的核桃放入太阳能核桃破壳机进行破碎，破碎后分离核桃壳和核桃仁，然后将分离出来的核桃仁进行超微粉碎，形成核桃粉；将经步骤1处理后的黑芝麻进行超微粉碎，形成黑芝麻粉；
步骤3、将经步骤1处理后的灵芝、茯苓放入浸提装置，在60～70℃下浸提3h，然后经过过滤、去除杂质，制得清澈透明液，即母液Ⅰ；将经步骤1处理后的金银花、菊花、苦丁放入浸提装置，在60～70℃下浸提3h，然后经过过滤、去除杂质，制得清澈透明液，即母液Ⅱ；将经步骤1处理后的山药、芹菜分别进行打浆和过滤，制得山药汁和芹菜汁；
步骤4、将核桃粉、母液Ⅰ混合，再添加黑芝麻粉、茶多酚和GABA，混合均匀后，加入适量蜂蜜进行调味，然后在压力为15～20Mpa的条件下进行均质，均质后在温度为138℃的条件下进行超高温灭菌4s，最后，通过喷雾干燥制得减压营养粉；将核桃粉、母液Ⅰ和母液Ⅱ混合，再添加茶多酚和GABA，混合均匀后，加入适量蜂蜜进行调味，然后在压力为15～20Mpa的条件下进行均质，均质后在温度为138℃的条件下进行超高温灭菌4s，最后，通过无菌灌装制得减压花茶或者通过液体浓缩制得浓缩生产口服液；将核桃粉、母液Ⅰ、山药汁和芹菜汁混合，再添加茶多酚和GABA，混合均匀后，加入适量蜂蜜进行调味，然后在压力为15～20Mpa的条件下进行均质，均质后在温度为138℃的条件下进行超高温灭菌4s，最后，通过无菌灌装制得减压果蔬汁或者通过液体浓缩制得浓缩生产口服液。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410226715.9A CN103989206B (zh) | 2014-05-26 | 2014-05-26 | 一种含gaba的减压营养保健品及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410226715.9A CN103989206B (zh) | 2014-05-26 | 2014-05-26 | 一种含gaba的减压营养保健品及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103989206A true CN103989206A (zh) | 2014-08-20 |
| CN103989206B CN103989206B (zh) | 2016-06-01 |
Family
ID=51303746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410226715.9A Active CN103989206B (zh) | 2014-05-26 | 2014-05-26 | 一种含gaba的减压营养保健品及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103989206B (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104382170A (zh) * | 2014-11-27 | 2015-03-04 | 苏州嘉禧萝生物科技有限公司 | 一种含有gaba的健康饮品 |
| CN104543703A (zh) * | 2014-11-27 | 2015-04-29 | 苏州嘉禧萝生物科技有限公司 | 一种高含量gaba的保健米粉 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101940325A (zh) * | 2010-07-15 | 2011-01-12 | 福建康之味食品工业有限公司 | 一种含γ-氨基丁酸的运动饮料 |
| CN102038248A (zh) * | 2010-11-01 | 2011-05-04 | 华润怡宝食品饮料（深圳）有限公司 | 一种舒缓饮料 |
| CN102423073A (zh) * | 2011-11-28 | 2012-04-25 | 李超建 | 食疗养生膳食 |
-
2014
- 2014-05-26 CN CN201410226715.9A patent/CN103989206B/zh active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101940325A (zh) * | 2010-07-15 | 2011-01-12 | 福建康之味食品工业有限公司 | 一种含γ-氨基丁酸的运动饮料 |
| CN102038248A (zh) * | 2010-11-01 | 2011-05-04 | 华润怡宝食品饮料（深圳）有限公司 | 一种舒缓饮料 |
| CN102423073A (zh) * | 2011-11-28 | 2012-04-25 | 李超建 | 食疗养生膳食 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104382170A (zh) * | 2014-11-27 | 2015-03-04 | 苏州嘉禧萝生物科技有限公司 | 一种含有gaba的健康饮品 |
| CN104543703A (zh) * | 2014-11-27 | 2015-04-29 | 苏州嘉禧萝生物科技有限公司 | 一种高含量gaba的保健米粉 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103989206B (zh) | 2016-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106962506A (zh) | 一种调和油及其制备方法 | |
| CN104287013A (zh) | 一种降血脂降血糖功能性保健醋饮料及其生产工艺 | |
| CN102106580A (zh) | 一种醒酒护肝保健饮料 | |
| CN106689948B (zh) | 一种胶原蛋白复合亚麻酸饮料及其制备方法 | |
| CN105309979A (zh) | 食用菌功能饮品及其制备方法 | |
| CN104304499A (zh) | 山楂核桃乳及其制备方法 | |
| CN107996927A (zh) | 提高免疫力的组合物、饮料及其制备方法 | |
| CN102090459A (zh) | 一种绞股蓝营养保健豆腐 | |
| CN104544400B (zh) | 一种含冬虫夏草提取物的复配保健饮料的制备方法 | |
| CN101564180B (zh) | 一种核桃全营养素在制备益智和增强免疫力的药品或保健品中的应用 | |
| CN102823654A (zh) | 系列中药保健奶片及其制备方法 | |
| CN101133837A (zh) | 一种鹰嘴豆营养粉及其制备方法 | |
| CN103750464A (zh) | 一种山菇益智功能饮料及其制备方法 | |
| CN107446790A (zh) | 一种果醋养生饮料及其制备方法 | |
| CN108651635A (zh) | 具有健脑补脑功效的营养均衡的健康食用油 | |
| CN103989206A (zh) | 一种含gaba的减压营养保健品及其制备方法 | |
| CN104171485A (zh) | 一种抗衰老蜂蜜 | |
| CN103789116A (zh) | 一种脱醇山楂酒 | |
| CN100353865C (zh) | 虫草手参组合系列保健品 | |
| CN105360354A (zh) | 一种美容护肤葡萄籽油及其制备方法 | |
| CN105936847A (zh) | 防衰老葡萄酒及其制备工艺 | |
| CN103829342A (zh) | 功能性保健饮料及其制备方法 | |
| CN102599512A (zh) | 一种沙棘营养粉及其制备方法 | |
| KR101800787B1 (ko) | 홍삼 시래기밥의 제조방법 | |
| CN1395880A (zh) | 灵芝木耳生物保健饮料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C53 | Correction of patent of invention or patent application | ||
| CB02 | Change of applicant information |
Address after: 310000, 1102, Xicheng, 98, ancient Pier Road, Zhejiang, Hangzhou Applicant after: Cheng Lihua Address before: 246670, room 09, shop No. 303, Front Inn, Anqing Town, Yuexi County, Anhui, China Applicant before: Cheng Lihua |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP02 | Change in the address of a patent holder |
Address after: Shogun East Gulou District of Nanjing city of Jiangsu Province, No. 199 210000 Patentee after: Cheng Lihua Address before: 1102, Xicheng new building, No. 98, gudun Road, Hangzhou, Zhejiang Patentee before: Cheng Lihua |
|
| CP02 | Change in the address of a patent holder | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20211018 Granted publication date: 20160601 |
|
| PP01 | Preservation of patent right |